Macquarie Upgrades CME Group to “Outperform”; Sees 42% Upside (CME)

By
A A A
Share |

Futures exchange operator CME Group Inc. ( CME ) on Thursday caught a big upgrade from analysts at Macquarie Group.

The firm said it boosted its rating on CME from "Neutral" to "Outperform" with a $344 price target. That new target suggests a massive 43% upside to the stock's Wednesday closing price of $241.34.

CME Group shares, which have lost 25% of their value year-to-date, rose $1.73, or +0.7%, in premarket trading Thursday.


The Bottom Line
Shares of CME Group ( CME ) have a 2.32% dividend yield, based on last night's closing stock price of $241.34. The stock has technical support in the $222-$237 price area. If the shares can firm up, we see overhead resistance around the $250-$253 price levels.

CME Group Inc. ( CME ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: CME

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

67%

Most Active by Volume

33,110,376
  • $113.99 ▲ 1.77%
25,034,179
    $17.98 unch
24,486,872
  • $7.41 ▲ 2.07%
20,864,535
  • $7.39 ▼ 2.76%
18,600,501
  • $8.30 ▼ 0.36%
17,530,211
  • $8.14 ▲ 3.17%
17,299,208
  • $93.79 ▲ 2.74%
14,669,760
  • $25.78 ▼ 0.19%
As of 12/26/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com